Birgit Girshick joined Charles River in 1989 and held positions of increasing responsibility in the Company’s Research Models & Services and Avian Vaccine Services businesses. In 2004, Ms. Girshick was promoted to General Manager of the Avian Vaccine Services business. She was named Corporate Vice President, Global Biopharmaceutical Services (now Biologics Testing Solutions), in 2010. In 2013, Ms. Girshick was promoted to Corporate Senior Vice President, Research Models and Biologics Testing Solutions. In 2016, Ms. Girshick assumed responsibility for leading the WIL integration, and in October 2016, was named head of the global Discovery Services business.
In 2018, Ms. Girshick was promoted to Corporate Executive Vice President overseeing the Discovery, Safety Assessment, Biologics Testing Solutions, and Avian Vaccine Services businesses. In 2021, she also assumed responsibility for the company’s Cell and Gene Therapy CDMO business. In October 2021, Ms. Girshick was promoted to Chief Operating Officer, and assumed the additional oversight of the Research Models and Services business, where she began her Charles River career in 1989. In the Chief Operating Officer role, Ms. Girshick is responsible for leading the Company’s global business units, which includes guiding their strategic direction, driving operational excellence and growth, maintaining client and partnership relationships, leading the organization’s digital transformation and integrating acquisitions. She is a member of the company’s Executive Committee.
Ms. Girshick received a B.A. degree from Eastern Connecticut State University and an M.B.A. degree from the University of Rhode Island. She also received a certificate from the Advanced Management Program from Massachusetts Institute of Technology’s Sloan School of Management.
What is Birgit Girshick's net worth?
The estimated net worth of Birgit Girshick is at least $8.95 million as of November 20th, 2023. Ms. Girshick owns 44,449 shares of Charles River Laboratories International stock worth more than $8,945,361 as of December 3rd. This net worth approximation does not reflect any other investments that Ms. Girshick may own. Additionally, Ms. Girshick receives an annual salary of $1,280,000.00 as VP at Charles River Laboratories International. Learn More about Birgit Girshick's net worth.
How old is Birgit Girshick?
Ms. Girshick is currently 54 years old. There are 5 older executives and no younger executives at Charles River Laboratories International. The oldest executive at Charles River Laboratories International is Mr. James C. Foster J.D., CEO, President & Chairman, who is 73 years old. Learn More on Birgit Girshick's age.
What is Birgit Girshick's salary?
As the VP of Charles River Laboratories International, Inc., Ms. Girshick earns $1,280,000.00 per year. There are 2 executives that earn more than Ms. Girshick. The highest earning executive at Charles River Laboratories International is Mr. James C. Foster J.D., CEO, President & Chairman, who commands a salary of $2,660,000.00 per year. Learn More on Birgit Girshick's salary.
How do I contact Birgit Girshick?
Has Birgit Girshick been buying or selling shares of Charles River Laboratories International?
Birgit Girshick has not been actively trading shares of Charles River Laboratories International over the course of the past ninety days. Most recently, on Monday, November 20th, Birgit Girshick bought 1,322 shares of Charles River Laboratories International stock. The stock was acquired at an average cost of $187.82 per share, with a total value of $248,298.04. Following the completion of the transaction, the chief operating officer now directly owns 44,449 shares of the company's stock, valued at $8,348,411.18. Learn More on Birgit Girshick's trading history.
Who are Charles River Laboratories International's active insiders?
Charles River Laboratories International's insider roster includes William Barbo (VP), Robert Bertolini (Director), Stephen Chubb (Director), Victoria Creamer (EVP), James Foster (CEO), Birgit Girshick (VP), Michael Knell (CAO), Deborah Kochevar (Director), Joseph LaPlume (EVP), George Massaro (Director), Shannon Parisotto (EVP), David Smith (CFO), and Richard Wallman (Director). Learn More on Charles River Laboratories International's active insiders.
Are insiders buying or selling shares of Charles River Laboratories International?
During the last year, insiders at the medical research company sold shares 5 times. They sold a total of 22,857 shares worth more than $5,420,562.80. The most recent insider tranaction occured on November, 7th when Director Richard F Wallman sold 6,621 shares worth more than $1,430,930.52. Insiders at Charles River Laboratories International own 1.3% of the company.
Learn More about insider trades at Charles River Laboratories International. Information on this page was last updated on 11/7/2024.
